Quantitative comparison of stem cell marker-positive cells in fetal and term human amnion

Journal of Reproductive Immunology

Volumn 81, Issue 1, 2009, Pages 39-43

  Izumi, Masanori ^a,c   Pazin, Benjamin J ^a,c   Minervini, Crescenzio F ^a,c   Gerlach, Jörg ^a,c   Ross, Mark A ^b   Stolz, Donna B ^b,c   Turner, Morris E ^d   Thompson, Robert L ^d   Miki, Toshio ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Allegheny Reproductive Health Center   (United States)

Author keywords

Amnion; Human; Immunofluorescence; Placenta; Pluripotent stem cells

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR REJECTION ANTIGEN; TUMOR REJECTION ANTIGEN 1-60; TUMOR REJECTION ANTIGEN 1-81; UNCLASSIFIED DRUG;

AMNION CELL; ARTICLE; CONTROLLED STUDY; ECTODERM; FETUS; FETUS CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MARKER GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AMNION; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; EPITHELIAL CELLS; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; OCTAMER TRANSCRIPTION FACTOR-3; PLACENTA; PLURIPOTENT STEM CELLS; PREGNANCY; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS;

EID: 67649807464     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.02.007     Document Type: Article

References (21)

1. Akle C.A., Adinolfi M., Welsh K.I., Leibowitz S., and McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2 8254 (1981) 1003-1005
2. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., and Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17 1 (2003) 126-140
3. Badcock G., Pigott C., Goepel J., and Andrews P.W. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res. 59 18 (1999) 4715-4719
4. Bautzmann H., and Hertenstein C. Histogenesis and histology of the human fetal and newborn amnion. Z. Zellforsch. Mikrosk Anat. 45 5 (1957) 589-611
5. Carlson B.M. Human Embryology & Developmental Biology (1999), Mosby, Inc., St. Louis, MO pp. 59-63
6. Henderson J.K., Draper J.S., Baillie H.S., Fishel S., Thomson J.A., Moore H., and Andrews P.W. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20 4 (2002) 329-337
7. Ilancheran S., Michalska A., Peh G., Wallace E.M., Pera M., and Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol. Reprod. 77 3 (2007) 577-588
8. Liedtke S., Stephan M., and Kogler G. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol. Chem. 389 7 (2008) 845-850
9. Miki T., Lehmann T., Cai H., Stolz D.B., and Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23 10 (2005) 1549-1559
10. Miki T., Mitamura K., Ross M.A., Stolz D.B., and Strom S.C. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J. Reprod. Immunol. 75 2 (2007) 91-96
11. Miki T., and Strom S.C. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2 2 (2006) 133-142
12. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., and Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 5 (2003) 631-642
13. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 3 (1998) 379-391
14. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 4 (2000) 372-376
15. Parolini O., Alviano F., Bagnara G.P., Bilic G., Buhring H.J., Evangelista M., Hennerbichler S., Liu B., Magatti M., Mao N., Miki T., Marongiu F., Nakajima H., Nikaido T., Portmann-Lanz C.B., Sankar V., Soncini M., Stadler G., Surbek D., Takahashi T.A., Redl H., Sakuragawa N., Wolbank S., Zeisberger S., Zisch A., and Strom S.C. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26 2 (2008) 300-311
16. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., and Robson P. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280 26 (2005) 24731-24737
17. Scaggiante B., Pineschi A., Sustersich M., Andolina M., Agosti E., and Romeo D. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 44 1 (1987) 59-61
18. Temel R.E., Lee R.G., Kelley K.L., Davis M.A., Shah R., Sawyer J.K., Wilson M.D., and Rudel L.L. Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2. J. Lipid Res. 46 11 (2005) 2423-2431
19. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 5391 (1998) 1145-1147
20. Tylki-Szymanska A., Maciejko D., Kidawa M., Jablonska-Budaj U., and Czartoryska B. Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases. J. Inherit. Metab. Dis. 8 3 (1985) 101-104
21. Wynn R.M., and French G.L. Comparative ultrastructure of the mammalian amnion. Obstet. Gynecol. 31 6 (1968) 759-774